INTERVIEW: EUROPEAN UNION - COMPETITION POLICY - HEALTH CRISIS
Olivier Guersent (DG COMP): European competition policy in the context of crisis
*This article is an automatic translation of the original article, provided here for your convenience. Read the original article.
A conversation with :
- Thierry Boillot Director of Competition, AFEC - AFJE, Paris
- Muriel Chagny Professor, University of Versailles-Saint-Quentin-en-Yvelines (Paris-Saclay) and President, AFEC, Paris
- Jacques Derenne Partner, Sheppard Mullin, Brussels and Professor, University of Liège
- Frédéric Jenny Professor, ESSEC Business School, Cergy
- Michel Ponsard Partner, UGGC Avocats, Paris and Vice-President, AFEC, Paris
- Stéphanie Yon-Courtin Member of the European Parliament (France), Renew Europe Group, European Parliament, Brussels
Muriel Chagny: When, in my capacity as President of the French Association for Competition Studies (AFEC), I invited you to speak at one of our events, I thought I would have the pleasure of welcoming you in person in Paris. Unfortunately, the health crisis has come and gone. We have had to adapt by resorting to webconferencing, which also concerned the working groups we regularly organise on current or anticipatory topics. The AFEC could not stay away from the debates and speculations on the impact of Covid 19 on competition policy and law, both in the immediate and more or less long term. AFEC therefore set up a working group with this "competition law and health crisis" in mind.
Allow me, Mr. Director General, to reiterate my thanks to you for agreeing to take part in this web
Access to this article is restricted to subscribers
Already Subscribed? Sign-in